The purified component of hematoporphyrin derivative, it consists of a mixture of oligomeric porphyrins. It is used in photodynamic therapy (hematoporphyrin photoradiation); to treat malignant lesions with visible light and experimentally as an antiviral agent. It is the first drug to be approved in the use of photodynamic therapy in the United States.
Fitur visualisasi ini dikembangkan menggunakan pendekatan Graph Theory untuk memetakan hubungan polifarmasi dan molekuler. Entitas (Obat, Target, Gen) direpresentasikan sebagai Simpul (Nodes), sedangkan hubungan biologisnya sebagai Sisi (Edges).
drugbank-id dan name pada skema XML DrugBank.targets/target yang memuat polipeptida sasaran.gene-name dan varian snp-effects.Tata letak grafik menggunakan algoritma Force-Directed Graph (Barnes-Hut). Model fisika ini menerapkan gaya tolak-menolak antar simpul (Gravitasi: -3000) agar tidak tumpang tindih, serta gaya pegas (Spring: 0.04) pada garis penghubung untuk fleksibilitas interaksi.
| Riboflavin | Riboflavin may increase the photosensitizing activities of Porfimer sodium. |
| Verteporfin | Verteporfin may increase the photosensitizing activities of Porfimer sodium. |
| Methoxsalen | Methoxsalen may increase the photosensitizing activities of Porfimer sodium. |
| Carprofen | Carprofen may increase the photosensitizing activities of Porfimer sodium. |
| Aminolevulinic acid | Aminolevulinic acid may increase the photosensitizing activities of Porfimer sodium. |
| Tiaprofenic acid | Tiaprofenic acid may increase the photosensitizing activities of Porfimer sodium. |
| Protoporphyrin | Protoporphyrin may increase the photosensitizing activities of Porfimer sodium. |
| Trioxsalen | Trioxsalen may increase the photosensitizing activities of Porfimer sodium. |
| Acetophenone | Acetophenone may increase the photosensitizing activities of Porfimer sodium. |
| Motexafin lutetium | Motexafin lutetium may increase the photosensitizing activities of Porfimer sodium. |
| Motexafin gadolinium | Motexafin gadolinium may increase the photosensitizing activities of Porfimer sodium. |
| Hexaminolevulinate | Hexaminolevulinate may increase the photosensitizing activities of Porfimer sodium. |
| Rostaporfin | Rostaporfin may increase the photosensitizing activities of Porfimer sodium. |
| Cyamemazine | Cyamemazine may increase the photosensitizing activities of Porfimer sodium. |
| Temoporfin | Temoporfin may increase the photosensitizing activities of Porfimer sodium. |
| Talaporfin | Talaporfin may increase the photosensitizing activities of Porfimer sodium. |
| Bergapten | Bergapten may increase the photosensitizing activities of Porfimer sodium. |
| Dihematoporphyrin ether | Dihematoporphyrin ether may increase the photosensitizing activities of Porfimer sodium. |
| Titanium dioxide | Titanium dioxide may increase the photosensitizing activities of Porfimer sodium. |
| Clofazimine | Clofazimine may increase the photosensitizing activities of Porfimer sodium. |
| Vemurafenib | Vemurafenib may increase the photosensitizing activities of Porfimer sodium. |
| Metoprolol | Metoprolol may increase the photosensitizing activities of Porfimer sodium. |
| Methotrimeprazine | Methotrimeprazine may increase the photosensitizing activities of Porfimer sodium. |
| Nilotinib | Nilotinib may increase the photosensitizing activities of Porfimer sodium. |
| Methylene blue | Methylene blue may increase the photosensitizing activities of Porfimer sodium. |
| Dabrafenib | Dabrafenib may increase the photosensitizing activities of Porfimer sodium. |
| Febuxostat | Febuxostat may increase the photosensitizing activities of Porfimer sodium. |
| Fosdenopterin | Fosdenopterin may increase the photosensitizing activities of Porfimer sodium. |
| Cyproheptadine | Cyproheptadine may increase the photosensitizing activities of Porfimer sodium. |
| Hemoporfin | Hemoporfin may increase the photosensitizing activities of Porfimer sodium. |
| Tretinoin | The risk or severity of adverse effects can be increased when Tretinoin is combined with Porfimer sodium. |
| Darbepoetin alfa | The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Porfimer sodium. |
| Erythropoietin | The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Porfimer sodium. |
| Peginesatide | The risk or severity of Thrombosis can be increased when Peginesatide is combined with Porfimer sodium. |
| Methoxy polyethylene glycol-epoetin beta | The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol-epoetin beta is combined with Porfimer sodium. |
| Levofloxacin | Levofloxacin may increase the photosensitizing activities of Porfimer sodium. |
| Padeliporfin | Porfimer sodium may increase the photosensitizing activities of Padeliporfin. |
| Lidocaine | The risk or severity of methemoglobinemia can be increased when Porfimer sodium is combined with Lidocaine. |
| Ropivacaine | The risk or severity of methemoglobinemia can be increased when Porfimer sodium is combined with Ropivacaine. |
| Bupivacaine | The risk or severity of methemoglobinemia can be increased when Porfimer sodium is combined with Bupivacaine. |
| Cinchocaine | The risk or severity of methemoglobinemia can be increased when Porfimer sodium is combined with Cinchocaine. |
| Dyclonine | The risk or severity of methemoglobinemia can be increased when Porfimer sodium is combined with Dyclonine. |
| Procaine | The risk or severity of methemoglobinemia can be increased when Porfimer sodium is combined with Procaine. |
| Prilocaine | The risk or severity of methemoglobinemia can be increased when Porfimer sodium is combined with Prilocaine. |
| Proparacaine | The risk or severity of methemoglobinemia can be increased when Porfimer sodium is combined with Proparacaine. |
| Meloxicam | The risk or severity of methemoglobinemia can be increased when Porfimer sodium is combined with Meloxicam. |
| Oxybuprocaine | The risk or severity of methemoglobinemia can be increased when Porfimer sodium is combined with Oxybuprocaine. |
| Cocaine | The risk or severity of methemoglobinemia can be increased when Porfimer sodium is combined with Cocaine. |
| Mepivacaine | The risk or severity of methemoglobinemia can be increased when Porfimer sodium is combined with Mepivacaine. |
| Levobupivacaine | The risk or severity of methemoglobinemia can be increased when Porfimer sodium is combined with Levobupivacaine. |
| Diphenhydramine | The risk or severity of methemoglobinemia can be increased when Porfimer sodium is combined with Diphenhydramine. |
| Benzocaine | The risk or severity of methemoglobinemia can be increased when Porfimer sodium is combined with Benzocaine. |
| Chloroprocaine | The risk or severity of methemoglobinemia can be increased when Porfimer sodium is combined with Chloroprocaine. |
| Phenol | The risk or severity of methemoglobinemia can be increased when Porfimer sodium is combined with Phenol. |
| Tetrodotoxin | The risk or severity of methemoglobinemia can be increased when Porfimer sodium is combined with Tetrodotoxin. |
| Benzyl alcohol | The risk or severity of methemoglobinemia can be increased when Porfimer sodium is combined with Benzyl alcohol. |
| Capsaicin | The risk or severity of methemoglobinemia can be increased when Porfimer sodium is combined with Capsaicin. |
| Etidocaine | The risk or severity of methemoglobinemia can be increased when Porfimer sodium is combined with Etidocaine. |
| Articaine | The risk or severity of methemoglobinemia can be increased when Porfimer sodium is combined with Articaine. |
| Tetracaine | The risk or severity of methemoglobinemia can be increased when Porfimer sodium is combined with Tetracaine. |
| Propoxycaine | The risk or severity of methemoglobinemia can be increased when Porfimer sodium is combined with Propoxycaine. |
| Pramocaine | The risk or severity of methemoglobinemia can be increased when Porfimer sodium is combined with Pramocaine. |
| Butamben | The risk or severity of methemoglobinemia can be increased when Porfimer sodium is combined with Butamben. |
| Butacaine | The risk or severity of methemoglobinemia can be increased when Porfimer sodium is combined with Butacaine. |
| Oxetacaine | The risk or severity of methemoglobinemia can be increased when Porfimer sodium is combined with Oxetacaine. |
| Ethyl chloride | The risk or severity of methemoglobinemia can be increased when Porfimer sodium is combined with Ethyl chloride. |
| Butanilicaine | The risk or severity of methemoglobinemia can be increased when Porfimer sodium is combined with Butanilicaine. |
| Metabutethamine | The risk or severity of methemoglobinemia can be increased when Porfimer sodium is combined with Metabutethamine. |
| Quinisocaine | The risk or severity of methemoglobinemia can be increased when Porfimer sodium is combined with Quinisocaine. |
| Lamotrigine | Lamotrigine may increase the photosensitizing activities of Porfimer sodium. |
| Oxcarbazepine | Oxcarbazepine may increase the photosensitizing activities of Porfimer sodium. |
| Dasatinib | Dasatinib may increase the photosensitizing activities of Porfimer sodium. |
| Ambroxol | The risk or severity of methemoglobinemia can be increased when Porfimer sodium is combined with Ambroxol. |
| Etrasimod | The risk or severity of immunosuppression can be increased when Porfimer sodium is combined with Etrasimod. |
| Celecoxib | Celecoxib may increase the photosensitizing activities of Porfimer sodium. |
| Itraconazole | Itraconazole may increase the photosensitizing activities of Porfimer sodium. |
| Losartan | Losartan may increase the photosensitizing activities of Porfimer sodium. |